An Observational Trial of Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
Electrical activity in the brain known as gamma brainwaves help connect and process information throughout the brain. These gamma waves are diminished in Alzheimer's disease. New research in Alzheimer's disease mouse models shows that exposure to light flickering at the rate of 40 flashes per second or 40Hz increased gamma brainwaves and led to clearing of beta amyloid plaques in the brain, a key abnormality in Alzheimer's disease. This project will test the ability of a novel iPad App (AlzLife https://www.alz.life/) that delivers light therapy at 40 Hz combined with cognitive therapy to improve cognition, function, and quality of life in Alzheimer's disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: t
View:
• Alzheimer's disease
• Cognitive Impairment
Locations
United States
Florida
Andrey Vyshedskiy
RECRUITING
Miami
Contact Information
Primary
Andrey Vyshedskiy, Ph.D.
vysha@bu.edu
(617) 433-7724
Time Frame
Start Date: 2018-01-01
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 2000
Treatments
Participants who adhere to the protocol
All participants are encouraged to exercise with AlzLife daily for 30 minutes a day. The actual duration is to be measured through participant's interactions with ALZLIFE. Participants adhere to the protocol if they exercise with AlzLife the minimum of 1hour/week.
Participants who do not adhere to the protocol
All participants are encouraged to exercise with AlzLife daily for 30 minutes a day. The actual duration is to be measured through participant's interactions with ALZLIFE. Participants do not adhere to the protocol if they exercise with AlzLife less than 1hour/week.
Related Therapeutic Areas
Sponsors
Leads: Alzheimer's Light LLC